ID
40525
Descrizione
LOCALIZED PROSTATE CANCER DATA COLLECTION Version 2.0.5 Revised: April 7th , 2017 www.ichom.org Notice: This work was conducted using resources from ICHOM, the International Consortium for Health Outcomes Measurement (www.ICHOM.org). The content is solely the responsibility of the authors and does not necessarily represent the official views of ICHOM. Conditions: Localized prostate cancer Treatment Approaches: Active Surveillance | Watchful Waiting | Radical Prostatectomy* | External Beam Radiation Therapy* | Androgen Deprivation Therapy (ADT)* | Focal Therapy* | Other* * These should also be collected as salvage treatments where necessary This ODM-file contains Baseline Clinical Form. To be used at baseline, i.e., post-diagnosis, pre-treatment. Please timestamp all variables. Some Standard Set variables are collected at multiple timepoints, and we will ask you to submit these variables in a concatenated VARIABLEID_TIMESTAMP form for future analyses. TEST StudyFor example, VARIABLEID_BASE (baseline); VARIABLEID_6MO (6 month follow-up); VARIABLEID_1YR (1 year follow-up), etc. Survey used: Expanded Prostate Cancer Index Composite (EPIC-26): The EPIC-26 is free for all health care organizations, and a license is not needed. The scoring guide may be found at http://www.med.umich.edu/urology/research/EPIC/EPIC-26-Scoring-1.2007.pdf ; Wei J, Dunn R, Litwin M, Sandler H, and Sanda M. "Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer", Urology. 56: 899-905, 2000. For registries choosing to implement the EPIC-CP rather than the EPIC-26, we recommend using the same variable IDs as the corresponding EPIC-26 questions. This means that only questions 2, 3, 4a, 4b, 4d, 4e, 5, 6e, 6b, 7, 8b, 9, 12, 13a, 13c, and 13d of the EPIC-26 are administered. Utilization of Sexual Medications/Devices: The Utilization of Sexual Medications/Devices is free for all health care organizations, and a license is not needed. Refer to http://dx.doi.org/10.1016/j.urology.2006.01.077 for more information European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ- PR25): The EORTC QLQ-PR25 is free for all health care organizations, but a license is needed for use. Therefore it will not be integrated in this Version of the questionnaire. For more information, please visit http://groups.eortc.be/qol/eortc-qlq-c30 . ICHOM was supported for this Localized Prostate Cancer Standard Set by the Movember Foundation. Publication: Martin NE, Massey L, Stowell C, et al. Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol. 2015;67(3):460‐467. doi:10.1016/j.eururo.2014.08.075 For this version of the standard set, semantic annotation with UMLS CUIs has been added.
collegamento
Keywords
versioni (2)
- 21/08/18 21/08/18 - Sarah Riepenhausen
- 30/04/20 30/04/20 - Sarah Riepenhausen
Titolare del copyright
ICHOM
Caricato su
30 aprile 2020
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
ICHOM Localized Prostate Cancer
Baseline Clinical Form
- StudyEvent: ODM
Descrizione
Baseline Tumor Factors
Alias
- UMLS CUI-1
- C0475752
- UMLS CUI-2
- C1442488
Descrizione
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical or administrative data TYPE: Date by DD/MM/YYYY RESPONSE OPTIONS: DD/MM/YYYY
Tipo di dati
date
Alias
- UMLS CUI [1,1]
- C2316983
- UMLS CUI [1,2]
- C0679557
- UMLS CUI [1,3]
- C0600139
Descrizione
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical value
Tipo di dati
float
Unità di misura
- ng/mL
Alias
- UMLS CUI [1,1]
- C0138741
- UMLS CUI [1,2]
- C0332152
- UMLS CUI [1,3]
- C0679557
- UMLS CUI [1,4]
- C0600139
Descrizione
Pathologic staging preferred, if available cT0: No evidence of primary tumor cT1: if not able to select cT1a, cT1b or cT1c: Clinically inapparent tumor neither palpable nor visible by imaging cT1a: Tumor incidental histologic finding in 5 percent or less of tissue resected cT1b: Tumor incidental histologic finding in more than 5 percent of tissue resected cT1c: Tumor identified by needle biopsy (eg, because of elevated PSA) cT2: if not able to select cT2a, cT2b or cT2c: Tumor confined within prostate* cT2a: Tumor involves one-half of one lobe or less cT2b: Tumor involves more than one-half of one lobe but not both lobes cT2c: Tumor involves both lobes cT3: if not able to select cT3a, cT3b or cT3c: Tumor extends through the prostate capsule cT3a: Extracapsular extension (unilateral or bilateral) cT3b: Tumor invades seminal vesicle(s) cT4: Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall cTX: Primary tumor cannot be assessed INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Single answer
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C0441915
- UMLS CUI [1,2]
- C0205210
- UMLS CUI [1,3]
- C0600139
Descrizione
Pathologic staging preferred, if available cNo: regional lymph node metastasis cN1: Metastasis in regional lymph node(s) cNX: Regional lymph nodes were not assessed INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Single answer
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C0456532
- UMLS CUI [1,2]
- C0441915
- UMLS CUI [1,3]
- C0205210
- UMLS CUI [1,4]
- C0600139
Descrizione
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical value
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C1275862
- UMLS CUI [1,2]
- C0600139
Descrizione
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C4528268
- UMLS CUI [1,2]
- C0600139
Descrizione
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical value
Tipo di dati
integer
Unità di misura
- %
Alias
- UMLS CUI [1]
- C1272841
Descrizione
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical value
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C1273604
- UMLS CUI [1,2]
- C0005558
Descrizione
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical TYPE: Numerical value
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C1273605
- UMLS CUI [1,2]
- C0005558
Similar models
Baseline Clinical Form
- StudyEvent: ODM
C1442488 (UMLS CUI-2)
C0679557 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,2])
C0679557 (UMLS CUI [1,3])
C0600139 (UMLS CUI [1,4])
C0205210 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0441915 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0600139 (UMLS CUI [1,4])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0600139 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,2])